1. Home
  2. LCTX vs SRTA Comparison

LCTX vs SRTA Comparison

Compare LCTX & SRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.49

Market Cap

407.7M

Sector

Health Care

ML Signal

HOLD

SRTA

Strata Critical Medical Inc.

N/A

Current Price

$4.14

Market Cap

472.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
LCTX
SRTA
Founded
1990
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
407.7M
472.4M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
LCTX
SRTA
Price
$1.49
$4.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$5.33
$7.81
AVG Volume (30 Days)
1.2M
755.1K
Earning Date
03-05-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,556,000.00
N/A
Revenue This Year
$55.75
$39.67
Revenue Next Year
$2.96
$8.84
P/E Ratio
N/A
$9.88
Revenue Growth
53.24
N/A
52 Week Low
$0.37
$3.85
52 Week High
$2.09
$6.02

Technical Indicators

Market Signals
Indicator
LCTX
SRTA
Relative Strength Index (RSI) 37.77 38.75
Support Level $0.94 $3.93
Resistance Level $1.84 $5.46
Average True Range (ATR) 0.09 0.20
MACD -0.02 -0.02
Stochastic Oscillator 15.91 8.89

Price Performance

Historical Comparison
LCTX
SRTA

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

About SRTA Strata Critical Medical Inc.

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. Its core services include air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.

Share on Social Networks: